未登录 分享 收藏
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy 含免疫治疗的三期泌尿生殖系统癌症试验中非免疫治疗组的分配 Grier, Abby L.; Jang, Albert; Zhong, Jeffrey Y.; Kumar, Hamsa L. S.; Jindal, Tanya; Calaway, Adam; Jia, Angela Y.; Fu, Pingfu; Bukavina, Laura; Ghandour, Rashed; Shoag, Jonathan E.; Vince, Randy; Rao, Santosh; Sheng, Iris; Mendiratta, Prateek; Brown, Jason R.; Gupta, Shilpa; Garcia, Jorge A.; Barata, Pedro C. 分享 收藏
分享 收藏
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer Center 免疫相关不良事件、生存结局及III期黑色素瘤患者后续治疗:一家国家癌症研究所指定的综合癌症中心的真实世界经验 Zablonski, Kevin G.; Boone, Jarred M.; Margevicius, Seunghee; Chakraborty, Natalie N.; Fu, Pingfu; Seibert, Hailey; Bhatty, Maira A.; Mirsky, Matthew; Bruno, Debora; Mangla, Ankit; Hoehn, Richard S.; Rothermel, Luke D.; Sheng, Iris Y. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Deep Learning Model of Primary Tumor and Metastatic Cervical Lymph Nodes From CT for Outcome Predictions in Oropharyngeal Cancer 基于CT图像的原发肿瘤和转移性颈淋巴结的深度学习模型,用于口咽癌的预后预测 Song, Bolin; Leroy, Amaury; Yang, Kailin; Khalighi, Sirvan; Pandav, Krunal; Dam, Tanmoy; Lee, Jonathan; Stock, Sarah; Li, Xiao T.; Sonuga, Jay; Fu, Pingfu; Koyfman, Shlomo; Saba, Nabil F.; Patel, Mihir R. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers Barnett, Reagan M.; Jang, Albert; Lanka, Sree; Fu, Pingfu; Bucheit, Leslie A.; Babiker, Hani; Bryce, Alan; Meyer, Haley M.; Choi, Yujin; Moore, Casey; Garje, Rohan; Gao, Xin; Kim, Dae Won; Chang, Richard Y.; Gulhati, Pat; Ramaker, Ryne; Bansal, Rani; Zhang, Tian; Oliver Sartor, A.; Armstrong, Andrew J.; Bilen, Mehmet A.; Barata, Pedro 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis 恩诺妥昔单抗(EV)在具有基线神经病变(N)和/或糖尿病(DM)的晚期尿路上皮癌(aUC)患者(pts)中的疗效:一项UNITE研究的分析 Jang, A.; Jindal, T.; Jiang, C. Y.; Nguyen, C. B.; Nizam, A.; Alva, A. S.; Grivas, P.; Bellmunt, J.; Hoimes, C. J.; Bilen, M. A.; Emamekhoo, H.; Milowsky, M. I.; Khaki, A. R.; Gupta, S.; Campbell, M. T.; Alhalabi, O.; Chen, Z.; Fu, P.; Koshkin, V. S.; Brown, J. R. 分享 收藏